UNSPSC 41151710: Benzodiazepine test system

In this classification, a Benzodiazepine test system is a device intended to measure Benzodiazepine for clinical toxicology purposes. US FDA regulates Benzodiazepine test system under 21 CFR 862.3170 and under FDA product code JXM

UNSPSC 41151710 Benzodiazepine test system is a Commodity code that shows no relevant recent state and local procurement activity. The code nominally covers laboratory testing systems for benzodiazepines, but the recent opportunities posted under this code do not match that scope — they instead describe acquisitions of scientific equipment, research instruments, and laboratory supplies spanning microscopy systems, analytical instruments, acoustic receivers, drone platforms, fire alarm components, and early childhood learning materials. These opportunities represent mislabeled or miscoded solicitations rather than benzodiazepine-specific test systems.

The issuing bodies in the recent-opportunities block are primarily Mississippi State University and the University of Mississippi, with occasional activity from other states — Texas State University, Midwestern State University, the University of Wisconsin-Madison, Illinois state agencies, Harris County Texas, and Oregon state departments. The solicitation mechanisms include sole-source notices (the dominant form), sealed-bid IFBs, and RFPs, with response dates spanning June through October 2026. Geographic concentration is heavy in Mississippi, particularly at Mississippi State University, which accounts for the plurality of notices. Without concrete, benzodiazepine-test-system solicitations anchoring the code's actual procurement profile, business development professionals should treat this code as currently inactive or significantly misaligned with how state and local buyers are tagging their actual purchases.